Clinical Trials

Showing 1 - 20 of 507 trials
Title Investigatorsort icon Disease(s)
A Phase IB Study of GDC-0199 (ABT-199 or Venetoclax) with R-CHOP or G-CHOP in Patients with B-Cell Non-Hodgkin Lymphoma
[Protocol 14-130]
Zelenetz, Andrew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase Ib Study of Urelumab Given with Rituximab in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Relapsed/Refractory
[Protocol 13-252]
Zelenetz, Andrew
  • Leukemia
    • Chronic Lymphocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients with Metastatic Cancer
[Protocol 10-154]
Zelefsky, Michael
A Phase II Study of VS-6063 in Patients with Malignant Pleural Mesothelioma
[Protocol 13-185]
Zauderer, Marjorie
  • Mesothelioma
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
[Protocol 11-112]
Zaider, Talia
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
A Two-Stage Pilot Study of PEGPH20 and Cetuximab in Patients with Pancreatic Cancer When Given Before Tumor Removal
[Protocol 14-039]
Yu, Kenneth
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I/II Study of Ruxolitinib plus Erlotinib in Patients with Erlotinib-Resistant Lung Adenocarcinoma
[Protocol 14-043]
Yu, Helena
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of ASP8273 in Patients with Non-Small Cell Lung Cancer and EGFR Mutations
[Protocol 14-128]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase I Study of Daily Low-Dose Erlotinib and Twice Weekly High-Dose Erlotinib in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
[Protocol 12-278]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase II Study of CO-1686 in Patients with Previously Treated Non-Small Cell Lung Cancer Containing an EGFR T790M Mutation
[Protocol 14-084]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase Ib Study of AZD9291 as Part of Combination Therapy in Patients with Non-Small Cell Lung Cancer which Has Continued to Grow Despite EGFR-Targeting Therapy
[Protocol 14-161]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase II Study to See if Carvedilol Can Help Prevent Heart Function Problems in Women Receiving Anthracyclines or Anti-HER2 Therapies for Breast Cancer
[Protocol 14-099]
Yu, Anthony
  • Breast Cancer
A Pilot Study of Functional Imaging for Cerebellar Mutism Syndrome
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-121]
Young, Robert
  • Pediatric Brain Tumors
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229]
Young, James
  • Melanoma
A Phase I Study of CPI-0610 in Patients with Progressive Lymphoma
Relapsed/Refractory
[Protocol 13-259]
Younes, Anas
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
Relapsed/Refractory
[Protocol 13-045]
Younes, Anas
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Nivolumab in Patients with Classical Hodgkin Lymphoma that Has Returned After Autologous Stem Cell Transplantation
[Protocol 14-147]
Younes, Anas
  • Lymphoma
    • Hodgkin's Disease
A Phase III Study of Ibrutinib (PCI-32765) plus R-CHOP Chemotherapy in Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL)
[Protocol 13-146]
Younes, Anas
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of CB-839 in Patients with Advanced or Persistent Hematologic Cancers
[Protocol 14-053]
Younes, Anas
  • Hematology
    • Hematologic Malignancies
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Mocetinostat in Patients with Diffuse Large B-cell Lymphoma or Follicular Lymphoma with Certain Mutations
[Protocol 14-106]
Younes, Anas
  • Lymphoma
    • Non-Hodgkin's Lymphoma